Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 25, 2025 09:15 ET | Source: Research and Markets

Regenerative Drugs Market Review 2020-2024 and Forecast 2025-2030: A $29 Billion Opportunity Led by Baxter International, Stryker Corporation and Medtronic

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Drugs Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering. The Global Regenerative Drugs Market...
September 25, 2025 08:53 ET | Source: Research and Markets

Regenerative Medicine Industry Trends and Growth Strategies, 2025-2030 Featuring Novartis, Biogen, GlaxoSmithKline, Baxter International, and Boehringer Ingelheim

Dublin, Sept. 25, 2025 (GLOBE NEWSWIRE) -- The "Regenerative Medicine Market - Forecasts from 2025 to 2030" has been added to ResearchAndMarkets.com's offering.The global regenerative medicine...
September 24, 2025 10:07 ET | Source: Pluristyx, Inc.

Pluristyx and Solesis Announce Strategic Collaboration to Advance Organoid and Cell Therapy Solutions

Pluristyx and Solesis partner to launch game-changing standardized organoid kits, powered by iPSC and polymer technologies.
September 19, 2025 04:23 ET | Source: Research and Markets

Biobanking Market Analysis and Forecast Report 2025-2035: Ethical and Legal Challenges in Biobanking - Navigating Consent and Privacy

Dublin, Sept. 19, 2025 (GLOBE NEWSWIRE) -- The "Biobanking Market - A Global and Regional Analysis: Focus on Product and Service, Storage Type, Sample Type, Ownership, Biobank Type, Application,...
September 18, 2025 05:36 ET | Source: Research and Markets

Europe Flow Cytometry Research Report 2025: Market to Surpass $2 Billion by 2035 - Expanding Use in Drug Discovery, Translational Research, and Clinical Trials

Dublin, Sept. 18, 2025 (GLOBE NEWSWIRE) -- The "Europe Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Europe flow cytometry...
September 17, 2025 10:30 ET | Source: Precedence Research

Regenerative Medicine Market Size Worth USD 1,69,586 Mn by 2034 Driven by Stem Cells, Innovation, and Investment in New Treatments

Ottawa, Sept. 17, 2025 (GLOBE NEWSWIRE) -- According to Statifacts, the global regenerative medicine market size surpassed USD 35,583 million in 2024 and is projected to hit approximately USD...
September 16, 2025 16:15 ET | Source: NurExone Biologic Inc

NurExone Planning to Establish First U.S. Commercial Manufacturing Facility in Indiana

TORONTO and HAIFA, Israel and INDIANAPOLIS, Sept. 16, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a biopharmaceutical...
September 16, 2025 06:04 ET | Source: Research and Markets

Asia-Pacific Flow Cytometry Research and Forecast Report 2025 | Market to Reach $1.91 Billion by 2035, Driven by Healthcare Expansion, Rising Chronic Disease Burden, and Surge in Personalized Medicine

Dublin, Sept. 16, 2025 (GLOBE NEWSWIRE) -- The "Asia-Pacific Flow Cytometry Market: Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets.com's offering.The Asia-Pacific...
September 08, 2025 16:30 ET | Source: NurExone Biologic Inc

NurExone Receives U.S. Patent Allowance for Exosome Manufacturing, Strengthening Supply Chain Readiness

TORONTO and HAIFA, Israel, Sept. 08, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a pioneering biopharmaceutical company...
September 04, 2025 07:07 ET | Source: Pluristyx, Inc.

Pluristyx and BioLamina Announce Strategic Partnership to Accelerate Development of Stem Cell-Based Therapies

Pluristyx & BioLamina partner to accelerate iPSC-based therapies with integrated cell culture solutions, for consistency, scalability & clinical success.